Pathological and genetic correlates of apoptosis in the progression of colorectal neoplasia

Tumor Biology

Volumn 18, Issue 3, 1997, Pages 146-156

  Hawkins, Nicholas ^a   Lees, Jacqueline ^a   Hargrove, Rebecca ^a   O’connor, Terence ^b   Meagher, Alan ^b   Ward, Robyn ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Apoptosis; Bcl 2; Colorectal neoplasia; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030925132     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1159/000218025     Document Type: Article

References (39)

1. Kerr JF, Wyllic AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics, Br J Cancer 1972;26:239-257.
2. Kerr JF, Winterford CM, Harmon BV: Apoptosis, Its significance in cancer and cancer therapy, Cancer 1994;73:2013-2026.
3. Gavrieli Y, Sherman Y, Ben SS: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol 1992;119:493-501.
4. Gold R, Schmied M, Rothe G, Zischler H, Breitschopf H, Wckcrle H, Lassmann H: Detection of DNA fragmentation in apoptosis: Application of in situ nick translation to cell culture systems and tissue sections, J Histochem Cytochem 1993; 41:1023-1030.
5. Ansari B, Coates PJ, Grecnstcin BD, Hall PA: In situ labelling detects DNA strand breaks in apoptosis and other physiological and pathological states, J Pathol 1993;170:1-8.
6. Wyllic AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endoculease activation, Nature 1980;284:555-556.
7. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE: Apoptosis in irradiated murine tumors, Radiat Res 1991;127:308-316.
8. Distelhorst CW: Glucocorticoste-roids induce DNA fragmentation in human lymphoid leukemia cells, Blood 1988;72:1305-1309.
9. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia, Biochem Pharmacol 1990; 40:2353-2362.
10. Hoffman B, Liebcrmann DA: Molecular controls of apoptosis: Differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive and negative modulators, Oncogene 1994:9:1807-1812.
11. Lane DP: Cancer, p53, guardian of the genome, Nature 1992;358:15- 16.
12. Williams GT, Smith CA: Molecular regulation of apoptosis: Genetic controls on cell death, Cell 1993:74: 777-779.
13. Scarle J, Collins DJ, Harmon B, Kerr JF: The spontaneous occurrence of apoptosis in squamous carcinomas of the uterine cervix, Pathology 1973;5:163-169.
14. Kerr JF, Scarle J: A suggested explanation for the paradoxically slow growth rate of basal-cell carcinomas that contain numerous mitotic figures, J Pathol 1972;107:41-44.
15. El-Labban N, Osorio-Herrcra H: Apoptotic bodies and abnormally dividing epithelial cells in squamous cell carcinoma, Histopathology 1986;10:921-931.
16. Del Vccchio MT, Leoncini L, Buer-ki K, Kraft R, Megha T, Barbini P, Tosi P, Cottier H: Diffuse ccntrocyt-ic and/or ccntroblastic malignant non-Hodgkin’s lymphomas: Comparison of mitotic and pyknotic (apoptotic) indices, Int J Cancer 1991;47:38-43.
17. Sinicrope FA, Ruan SB, Cleary KR, Stephens C, Lee JJ, Levin B: bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis, Cancer Res 1995;55:237-241.
18. Bcdi A, Pasricha PJ, Akhtar AJ, Barber JP, Bcdi GC, Giardiello FM, Zchnbaucr BA, Hamilton SR, Jones R: Inhibition of apoptosis during development of colorectal cancer, Cancer Res 1995;55:1811-1816.
19. Barctton GB, Diebold J, Christofo-ris G, Vogt M, Muller C, Dopfer K, Schncidcrbanger K, Schmidt M, Lohrs U: Apoptosis and immuno-histochcmical bcl-2 expression in colorectal adenomas and carcinomas - Aspects of carcinogenesis and prognostic significance, Cancer 1996;77:255-264.
20. Arai T, Kino I: Role of apoptosis in modulation of the growth of human colorectal tubular and villous adenomas, J Pathol 1995:176:37-44.
21. Lineweavcr W: Staging of colon cancer, Contemp Surg 1984:25:19.
22. Costa A, Maraska R, Valentinis B, Savarino M, Farada A, Silvestrini R, Torclli G: p53 gene point mutations in relation to p53 nucleoprotcin accumulation in colorectal cancers, J Pathol 1995:176:45-53.
23. McCarty KJ, Miller LS, Cox EB, Konrath J, MacCarty KS: Estrogen receptor analyses, Correlation of biochemical and immunohisto-chcmical methods using monoclonal antireceptor antibodies, Arch Pathol Lab Med 1985;109:716-721.
24. Altman DG: Practical Statistics for Medical Research, London, Chapman* Hall, 1993.
25. Gorczyca W, Gong J, Darzynkie-wicz, Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleo-tidyl transferase and nick translation assays, Cancer Res 1993:53: 1945-1951.
26. Gold R, Schmied M, Giegcrich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques, Lab Invest 1994:71:219-225.
27. Lee FD: Importance of apoptosis in the histopathology of drug related lesions in the large intestine, J Clin Pathol 1993;46:118-122.
28. Pasricha PJ, Bcdi A, O'Connor K, Rashid A, Akhtar AD, Zahurak ML, Piantadosi S, Hamilton SR, Giardiello FM: The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis, Gastroenterology 1995:109: 994-998.
29. Hamclin R, Laurcnt-Puig P, Olsch-wang S, Jego N, Asselan B, Rcmvi-kos Y, Girodct J, Salmon RJ, Thomas G: Association of p53 mutations with short survival in colorectal cancer, Gastroenterology 1994; 106:42-48.
30. Rcmvikos Y, Tominaga O, Hammel P, Laurcrt-Puig P, Salmon RJ, Du-trillaux B, Thomas G: Increased p53 protein content of colorectal tumors correlates with poor survival, Br J Cancer 1992;66:758-764.
31. Yamaguchi A, Nakagawara G, Ku-rosaka Y, Nishimura G, Yoncmura Y, Miyazaki I: p53 immunorcaction in endoscopy biopsy specimens of colorectal cancer, and its prognositc significance, Br J Cancer 1993:68: 399-402.
32. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P: p53 in colorectal cancer: Clinicopathologi-cal correlation and prognostic significance, Br J Cancer 1991:63:317-319.
33. Tanaka M, Omura K, Watanabe Y, Oda Y, Nakanishi I: Prognostic factors of colorectal cancer - K-ra.v mutation, overexpression of the p53-protein, and cell proliferative activ-tiy, J Surg Oncol 1994:57:57-64.
34. Purdie CA, O’Grady J, Piris J, Wyl-lie AH, Bird CC: p53 expression in colorectal tumors, Am J Pathol 1991;138:807-813.
35. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C: BCL-2 expression in human colorectal adenomas and carcinomas, Oncogene 1994;9:3367-3370.
36. Bronner MP, Culin C, Reed JC, Furth EE: The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model, Am J Pathol 1995;146:20-26.
37. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes, Cancer Res 1993;53:4701-4714.
38. Flohil CC, Janssen PA, Bosman FT: Expression of bcl-2 protein in hyperplastic polyps, adenomas and carcinomas of the colon, J Pathol 1996; 178:393-397.
39. Sinicrope FA, Hart J, Michclassi F, Lee JJ: Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma, Clin Cancer Res 1995;1:1103-1110.